Short Information | Oncocyte Corporation (NYSE:OCX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 673,223 |
Total Actual Volume | 29,099,775 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 33,661 |
Average Short Percentage | 2.32% |
Is there a OCX Short Squeeze or Breakout about to happen?
See the OCX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-19-2021 | $4.58 | $4.805 | $5 | $4.55 | 2,265,701 | 31,967 | 1.41% |
03-18-2021 | $4.81 | $4.53 | $4.92 | $4.5 | 728,026 | 9,151 | 1.26% |
03-05-2021 | $3.91 | $3.72 | $4.1 | $3.01 | 2,943,556 | 96,091 | 3.26% |
03-04-2021 | $4.6 | $3.9 | $4.6131 | $3.77 | 1,369,389 | 52,535 | 3.84% |
03-03-2021 | $4.66 | $4.33 | $4.78 | $4.24 | 1,126,697 | 17,708 | 1.57% |
03-02-2021 | $4.97 | $4.55 | $5.13 | $4.47 | 2,720,099 | 16,394 | 0.6% |
03-01-2021 | $5.13 | $4.88 | $5.24 | $4.87 | 1,267,579 | 10,623 | 0.84% |
02-26-2021 | $5.24 | $4.92 | $5.59 | $4.92 | 948,246 | 20,235 | 2.13% |
02-25-2021 | $5.6 | $5.34 | $5.8 | $5.23 | 791,594 | 22,374 | 2.83% |
02-24-2021 | $5.8 | $5.86 | $6.21 | $5.7173 | 537,357 | 15,984 | 2.97% |
02-23-2021 | $5.6 | $5.79 | $5.9238 | $5.23 | 1,422,454 | 32,419 | 2.28% |
02-22-2021 | $6.39 | $6.19 | $6.5 | $5.96 | 1,302,089 | 28,636 | 2.2% |
02-19-2021 | $5.55 | $6.34 | $6.5 | $5.55 | 1,124,516 | 9,132 | 0.81% |
02-18-2021 | $6.1 | $6.19 | $6.2917 | $5.6106 | 915,270 | 20,923 | 2.29% |
02-17-2021 | $6.49 | $6.37 | $6.49 | $6.2 | 923,566 | 12,924 | 1.4% |
02-16-2021 | $6.07 | $6.5 | $6.53 | $5.85 | 1,846,570 | 33,495 | 1.81% |
02-12-2021 | $5.69 | $5.92 | $5.97 | $5.51 | 984,455 | 45,109 | 4.58% |
02-11-2021 | $6.01 | $5.75 | $6.05 | $5.4 | 1,365,180 | 40,045 | 2.93% |
02-10-2021 | $6.45 | $5.85 | $6.57 | $5.35 | 2,573,168 | 61,279 | 2.38% |
02-09-2021 | $5.91 | $5.56 | $5.96 | $5.46 | 1,944,263 | 96,199 | 4.95% |
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Labora...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conferen...